Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
M. Yoshida (Tokyo, Japan), H. Fukano (Tokyo, Japan), K. Yamamoto (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), N. Hasegawa (Tokyo, Japan), S. Mitarai (Tokyo, Japan), M. Ato (Tokyo, Japan), Y. Hoshino (Tokyo, Japan)
Source: Virtual Congress 2020 – Translational science in respiratory infections
Session: Translational science in respiratory infections
Session type: E-poster session
Number: 2330
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Yoshida (Tokyo, Japan), H. Fukano (Tokyo, Japan), K. Yamamoto (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), N. Hasegawa (Tokyo, Japan), S. Mitarai (Tokyo, Japan), M. Ato (Tokyo, Japan), Y. Hoshino (Tokyo, Japan). Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.. 2330
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: